Long-term safety of cenobamate in Japanese people with partial seizures
Tests cenobamate over the long term in Japanese people with epilepsy and partial seizures.
Plain-language title generated from the registry record
Registry title: Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
Key facts
- Where
- Ehime, Fukushima, Hiroshima, Hokkaido, Hyōgo, Ibaraki, Kagoshima, Kanagawa, Kumamoto, Nagasaki, Osaka, Saitama, Shiga, Shizuoka, Tochigi, Tokushima, Tokyo, and Yamagata, JapanSee the 29 sites
- Phase
- Phase 2
Where in Japan
- Ehime University HospitalEhime, JapanTaking people
- Department of Neurology and Stroke Center, Southern Tohoku Clinic.Fukushima, JapanTaking people
- Hiroshima University HospitalHiroshima, JapanTaking people
- NHO Kure Medical Center and Chugoku Cancer CenterHiroshima, JapanTaking people
- Asahikawa Medical University HospitalHokkaido, JapanTaking people
- Itami City HospitalHyōgo, JapanTaking people
- JA-Ibaraki Tsuchiura Kyodo General HospitalIbaraki, JapanTaking people
- University of Tsukuba HospitalIbaraki, JapanTaking people
- Kagoshima University HospitalKagoshima, JapanTaking people
- Tanaka Neurosurgical ClinicKagoshima, JapanTaking people
- St. Marianna University School of Medicine HospitalKanagawa, JapanTaking people
- Yokohama City University HospitalKanagawa, JapanTaking people
- Kumamoto Ezuko Rehabilitation Medical CenterKumamoto, JapanTaking people
- NHO Nagasaki Medical CenterNagasaki, JapanTaking people
- Koide Clinic of Epilepsy and Neurological DisordersOsaka, JapanTaking people
- Osaka University HospitalOsaka, JapanTaking people
- Shintokukai Nii Neurosurgery and Psychiatry ClinicOsaka, JapanTaking people
- Ochiai Brain ClinicSaitama, JapanTaking people
- TMG Asaka Medical CenterSaitama, JapanTaking people
- Sakurai ClinicShiga, JapanTaking people
- NHO Shizuoka Institute of Epilepsy and Neurological DisordersShizuoka, JapanTaking people
- Seirei Hamamatsu General HospitalShizuoka, JapanTaking people
- Seirei Mikatahara General HospitalShizuoka, JapanTaking people
- Jichi Medical University HospitalTochigi, JapanTaking people
- Tokushima University HospitalTokushima, JapanTaking people
- Medical Hospital, Tokyo Medical and Dental UniversityTokyo, JapanTaking people
- National Center of Neurology and PsychiatryTokyo, JapanTaking people
- Tokyo Medical University HospitalTokyo, JapanTaking people
- NHO Yamagata National HospitalYamagata, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ono Pharmaceutical Co., Ltd.
- Trial code
- NCT06590896
- Record updated
- 3 June 2025
- Original description
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizuresRead full original descriptionShow less
A Phase 2, Multicenter Open-Label Extension Study to Evaluate the Long-term Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
Inclusion: Subjects completed Study YKP3089C035 by SK Life Science.
Exclusion: Subjects that have previously discontinued for any reason from the Core study (YKP3089C035); Any significant changes to the medical history of the subject that in the opinion of the investigator, could affect the safety of the subject.